212 related articles for article (PubMed ID: 12189383)
21. [Cellular immunotherapy for hematological malignancies].
Yasukawa M
Rinsho Ketsueki; 2008 Oct; 49(10):1460-71. PubMed ID: 18833930
[No Abstract] [Full Text] [Related]
22. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
23. [Immunology of tumors: correlation between immunological competence, clinical evolution and therapeutic response].
Kopersztych S; Naspitz CK; Mendes NF
Rev Hosp Clin Fac Med Sao Paulo; 1975; 30(6):513-6. PubMed ID: 1108153
[No Abstract] [Full Text] [Related]
24. Current developments of immunotherapy in the clinic.
Antonia S; Mulé JJ; Weber JS
Curr Opin Immunol; 2004 Apr; 16(2):130-6. PubMed ID: 15023403
[TBL] [Abstract][Full Text] [Related]
25. Considerations on clinical use of T cell immunotherapy for cancer.
Plautz GE; Cohen PA; Shu S
Arch Immunol Ther Exp (Warsz); 2003; 51(4):245-57. PubMed ID: 12956434
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
[TBL] [Abstract][Full Text] [Related]
27. Rational peptide-based tumour vaccine development and T cell monitoring.
Scheibenbogen C; Letsch A; Schmittel A; Asemissen AM; Thiel E; Keilholz U
Semin Cancer Biol; 2003 Dec; 13(6):423-9. PubMed ID: 15001161
[TBL] [Abstract][Full Text] [Related]
28. Introduction: diagnosis and immunotherapy of cancer.
Klein E
Natl Cancer Inst Monogr; 1972 Dec; 35():331-9. PubMed ID: 4349151
[No Abstract] [Full Text] [Related]
29. Vaccination for leukemia.
Molldrem JJ
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):13-8. PubMed ID: 16399579
[TBL] [Abstract][Full Text] [Related]
30. Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.
Sensi M; Anichini A
Clin Cancer Res; 2006 Sep; 12(17):5023-32. PubMed ID: 16951217
[TBL] [Abstract][Full Text] [Related]
31. Immunology and cancer.
Marchalonis J
Adv Pathobiol; 1976; 2():38-45. PubMed ID: 1088245
[No Abstract] [Full Text] [Related]
32. [Quantitative characteristics of the cellular link of immunity and a lymphocytic response to tumor-associated antigens in patients with tuberculosis and malignant neoplasms of the lung].
Autenshlius AI; Ivanova GG; Ogirenko AP; Ageeva TA; Vasil'ev NE
Probl Tuberk; 2002; (4):48-50. PubMed ID: 12125255
[TBL] [Abstract][Full Text] [Related]
33. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
Van den Eynde B
Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
[TBL] [Abstract][Full Text] [Related]
34. Cellular vaccine therapy for cancer.
Armstrong AC; Eaton D; Ewing JC
Expert Rev Vaccines; 2002 Oct; 1(3):303-16. PubMed ID: 12901571
[TBL] [Abstract][Full Text] [Related]
35. Tumor-associated antigens and the role of antibodies and cellular immunity in cancer. Introduction.
Vose B
Immunol Ser; 1994; 61():1-2. PubMed ID: 8011734
[No Abstract] [Full Text] [Related]
36. New frontiers in cell-based immunotherapy of cancer.
D'Elios MM; Del Prete G; Amedei A
Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy of prostate cancer.
Doehn C
Eur Urol; 2008 Apr; 53(4):681-3; discussion 684-5. PubMed ID: 18248878
[No Abstract] [Full Text] [Related]
38. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
Peggs KS; Quezada SA; Korman AJ; Allison JP
Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
[TBL] [Abstract][Full Text] [Related]
39. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
40. Antibodies in the treatment of lymphoma.
Leonard JP
Clin Adv Hematol Oncol; 2004 Apr; 2(4):210-1. PubMed ID: 16163182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]